UNSPSC 85521653: Replacement of right innominate vein with synthetic substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right innominate vein with synthetic substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 05R30JZ

UNSPSC 85521653 Replacement of right innominate vein with synthetic substitute, open approach is a Commodity code that shows little relevant recent state and local procurement activity. The code nominally describes a specific surgical procedure using a synthetic vascular graft, yet the most recent state and local opportunities posted under this code reflect occupational medical surveillance, pharmacy benefit management, disability medical evaluations, surgical benefit carve-outs through centers of excellence, emergency and specialty healthcare for youth in detention, and temporary health professional staffing — none of which involve synthetic vascular grafts or the replacement of the innominate vein. This mismatch suggests either a tagging error in the source material or that the code has been repurposed by state and local procurement systems in a manner disconnected from its UNSPSC definition.

The recent opportunities span four distinct states and county systems: Arizona (City of Phoenix Retirement Office), California (City of Long Beach and County of Santa Clara), Washington (Washington State Department of Transportation), Texas (Harris County Juvenile Probation Department), and Florida (Collier County Board of County Commissioners). These issuing bodies include city retirement offices, county health systems, state transportation departments, and juvenile probation departments — a diverse mix reflecting fragmented healthcare and human services procurement rather than a cohesive medical device or surgical supply procurement stream. No repeat buyers appear in the recent record, and no opportunities explicitly solicit synthetic vascular grafts, vein replacement materials, or open surgical vascular procedures. Given the absence of opportunities aligned with the code's stated scope, this code does not warrant active pursuit at this time.